Labs in Court: Two EKRA-Related Cases and Some Usual Suspects
Recent enforcement actions involved usual targets such as COVID-19, genetic, and urine drug testing, but EKRA also made an appearance
Practical, “What-to-Do” and “How-to-Do-It” Help to Comply with the Latest State & Federal Laws, Rules & Regulations that Affect Your Diagnostic Lab or Pathology Practice
Recent enforcement actions involved usual targets such as COVID-19, genetic, and urine drug testing, but EKRA also made an appearance
From - G2 Compliance Advisor
The U.S. Health and Human Services Office of Inspector General released its mid-year update to the Annual Work Plan, adding and revising items relevant to…
From - G2 Compliance Advisor
The U.S. Department of Health and Human Services' Office of Inspector General (OIG) touted its efforts and achievements for the six-month period ending…
From - G2 Compliance Advisor
For a third year in a row, the Centers for Medicare & Medicaid Services (CMS) has released updated data regarding Medicare payments with its Physician and…
From - G2 Compliance Advisor
The U.S. Health and Human Services Office of Inspector General's (OIG's) concern about kickbacks to referral sources is…
From - G2 Compliance Advisor
The False Claims Act (FCA) has become the federal government's primary weapon in combating fraud and abuse. However, most FCA cases are initiated not by the government but…